UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology

Science translational medicine, 2016-02, Vol.8 (324), p.324ps5

2016

Volltextzugriff (PDF)

Evaluation of the effect of food and ketoconazole on the pharmacokinetics of the smoothened inhibitor PF-04449913 in healthy volunteers

Cancer chemotherapy and pharmacology, 2014-08, Vol.74 (2), p.411-418

2014

Volltextzugriff (PDF)

Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies

Cancer research (Chicago, Ill.), 2011-02, Vol.71 (4), p.1362-1373

2011

Volltextzugriff (PDF)

Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study

The Lancet. Haematology, 2015-08, Vol.2 (8), p.e339-e346

2015

Volltextzugriff (PDF)

A phase I study of PF-04449913, an oral hedgehog inhibitor, in patients with advanced solid tumors

Clinical cancer research, 2015-03, Vol.21 (5), p.1044-1051

2015

Volltextzugriff (PDF)

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors

The oncologist (Dayton, Ohio), 2024-04, Vol.29 (4), p.e514-e525

2024

Volltextzugriff (PDF)

Studies of the HER-2/neu Proto-Oncogene in Human Breast and Ovarian Cancer

Science (American Association for the Advancement of Science), 1989-05, Vol.244 (4905), p.707-712

1989

Volltextzugriff (PDF)

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neu Oncogene

Science (American Association for the Advancement of Science), 1987-01, Vol.235 (4785), p.177-182

1987

Volltextzugriff (PDF)

First-in-human, phase I study of TT-00420, a multiple kinase inhibitor, as a single agent in advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3013-3013

2022

Volltextzugriff (PDF)

Phase I study of TT-00420, a multiple kinase inhibitor, as a single agent in advanced solid tumors

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3090-3090

2021

Volltextzugriff (PDF)

Economic Burden of Infections Following Allogeneic Hematopoietic Cell Transplant for Hematologic Malignancies

Blood, 2015-12, Vol.126 (23), p.4500-4500

2015

Volltextzugriff (PDF)

A Phase 1, Open Label Study To Evaluate The Drug Interaction Potential With Ketoconazole and The Effect Of Food On The Plasma Pharmacokinetics Of The Smoothened Inhibitor PF-04449913

Blood, 2013-11, Vol.122 (21), p.3857-3857

2013

Volltextzugriff (PDF)

Abstract LB095: ASPYRE-Lung addresses critical gaps in NGS-based biomarker testing: Robust variant calling from NGS QC fails

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.LB095-LB095

2024

Volltextzugriff (PDF)

Abstract 7622: ASPYRE-Lung: Validation of a simple, fast, robust and novel method for multi-variant genomic analysis of actionable NSCLC variants in tissue

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.7622-7622

2024

Volltextzugriff (PDF)

Ex Vivo Modulation of Donor Cells Results in Enhanced Survival and Reduced Gvhd Mortality

Blood, 2015-12, Vol.126 (23), p.1884-1884

2015

Volltextzugriff (PDF)

Abstract 5164: Deployment of ASPYRE-Lung targeted variant panel across three sites and testing with FFPE tissue and cytology-derived nucleic acid samples

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.5164-5164

2024

Volltextzugriff (PDF)

Human Blast Crisis Leukemia Stem Cell Inhibition with a Novel Smoothened Antagonist

Blood, 2010-11, Vol.116 (21), p.1223-1223

2010

Volltextzugriff (PDF)

Phase 1 Dose-Escalation Study of PF-04449913, An Oral Hedgehog (Hh) Inhibitor, in Patients with Select Hematologic Malignancies

Blood, 2011-11, Vol.118 (21), p.424-424

2011

Volltextzugriff (PDF)

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4010-4010

2012

Volltextzugriff (PDF)

Abstract A1: Phase 1 study of PF-03446962, a fully human mAb against activin receptor-like kinase 1 (ALK 1), a TGFβ receptor involved in tumor angiogenesis

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.A1-A1

2011

Volltextzugriff (PDF)

The murine eosinophil peroxidase gene (Epx) maps to chromosome 11

Mammalian genome, 1997-05, Vol.8 (5), p.381-382

1997

Volltextzugriff (PDF)

Tumor Suppressor and Immediate Early Transcription Factor Genes in Non-small Cell Lung Cancer

Chest, 1994-12, Vol.106 (6), p.372S-376S

1994

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(104)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Humans
(59)
Life Sciences & Biomedicine
(59)
Female
(36)
Male
(33)
Adult
(22)
Biological And Medical Sciences
(22)
Medical Sciences
(20)
Middle Aged
(17)
Adolescent
(14)
Social Sciences
(13)
Young Adult
(12)
Psychology
(11)
Treatment Outcome
(11)
Aged
(10)
Oncology
(10)
Animals
(8)
Psychology. Psychoanalysis. Psychiatry
(8)
Substance Abuse
(8)
Cancer
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology

Evaluation of the effect of food and ketoconazole on the pharmacokinetics of the smoothened inhibitor PF-04449913 in healthy volunteers

Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies

Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study

A phase I study of PF-04449913, an oral hedgehog inhibitor, in patients with advanced solid tumors

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors

Studies of the HER-2/neu Proto-Oncogene in Human Breast and Ovarian Cancer

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neu Oncogene

First-in-human, phase I study of TT-00420, a multiple kinase inhibitor, as a single agent in advanced solid tumors

Phase I study of TT-00420, a multiple kinase inhibitor, as a single agent in advanced solid tumors

Economic Burden of Infections Following Allogeneic Hematopoietic Cell Transplant for Hematologic Malignancies

A Phase 1, Open Label Study To Evaluate The Drug Interaction Potential With Ketoconazole and The Effect Of Food On The Plasma Pharmacokinetics Of The Smoothened Inhibitor PF-04449913

Abstract LB095: ASPYRE-Lung addresses critical gaps in NGS-based biomarker testing: Robust variant calling from NGS QC fails

Abstract 7622: ASPYRE-Lung: Validation of a simple, fast, robust and novel method for multi-variant genomic analysis of actionable NSCLC variants in tissue

Ex Vivo Modulation of Donor Cells Results in Enhanced Survival and Reduced Gvhd Mortality

Abstract 5164: Deployment of ASPYRE-Lung targeted variant panel across three sites and testing with FFPE tissue and cytology-derived nucleic acid samples

Human Blast Crisis Leukemia Stem Cell Inhibition with a Novel Smoothened Antagonist

Phase 1 Dose-Escalation Study of PF-04449913, An Oral Hedgehog (Hh) Inhibitor, in Patients with Select Hematologic Malignancies

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial

Abstract A1: Phase 1 study of PF-03446962, a fully human mAb against activin receptor-like kinase 1 (ALK 1), a TGFβ receptor involved in tumor angiogenesis

PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients

Gas1 and Kif27 Genes Are Strongly up-Regulated Biomarkers of Hedgehog Inhibition (PF-04449913) on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients

The murine eosinophil peroxidase gene (Epx) maps to chromosome 11

Cycling Toward Leukemia Stem Cell Elimination Wtih a Selective Sonic Hedgehog Antagonist

Tumor Suppressor and Immediate Early Transcription Factor Genes in Non-small Cell Lung Cancer

Suchergebnisse filtern